PsychonautWiki Archive

25I-NBOMe: Difference between revisions

← Older editNewer edit →
>Surgeon
>Surgeon
Substance template
Line 1: Line 1:
{| class="wikitable" align="right"
{{Substance
! colspan="2" style="background:lightblue;width:200px;font-size:10pt" | 25I-NBOMe
|name=25I-NBOMe
|-
|abbreviation=
| colspan="2" cellpadding="2" style="text-align:center;font-size:7pt" | [[Image:25I-NBOMe.png|noframe|218px]]
|img-skel=File:25I-NBOMe.png
 
|img-3d=
[[Image:25I-NBOMe-3d.png|noframe|218px]]<br />The skeletal formula of 25I-NBOMe.
|dosage-note=
|-
|dosage-method=sublingual
| colspan="2" style="background:lightblue;text-align:center;font-size:9pt" | '''Dosage (sublingual)'''
|dosage-threshold=50 - 250 µg
|-
|dosage-light=200 - 600 µg
| style="font-size:9pt" | Threshold || style="font-size:9pt" | 50-250<sub>µg</sub>
|dosage-common=500 - 800 µg
|-
|dosage-strong=700 - 1500 µg
| style="font-size:9pt" | Light || style="font-size:9pt" | 200-600<sub>µg</sub>
|dosage-heavy=
|-
|duration-method=
| style="font-size:9pt" | Common || style="font-size:9pt" | 500-800<sub>µg</sub>
|duration-total=6 - 10 hrs
|-
|duration-onset=15 - 120 mins
| style="font-size:9pt" | Strong || style="font-size:9pt" | 700-1500<sub>µg</sub>
|duration-coming-up=30 - 120 mins
|-
|duration-peak=2 - 4 hrs
| colspan="2" style="background:lightblue;text-align:center;font-size:9pt" | '''Duration'''
|duration-coming-down=1 - 4 hrs
|-
|duration-after-effects=5 - 24 hrs
| style="font-size:9pt" | Total Duration || style="font-size:9pt" | 6 - 10 hrs
}}
|-
| style="font-size:9pt" | Onset || style="font-size:9pt" | 15 - 120 mins
|-
| style="font-size:9pt" | Coming Up|| style="font-size:9pt" | 30 - 120 mins
|-
| style="font-size:9pt" | Peak || style="font-size:9pt" | 2 - 4 hrs
|-
| style="font-size:9pt" | Coming down || style="font-size:9pt" | 1 - 4 hrs
|-
| style="font-size:9pt" | After effects|| style="font-size:9pt" |5 - 24 hrs
 
|}


'''25I-NBOMe''' ('''2C-I-NBOMe''') is a derivative of the [[Phenethylamines|substituted phenethylamine]] [[Psychedelics|psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref> The chemical had no history of human use prior to being sold online as a [[designer drug]] in 2010.
'''25I-NBOMe''' ('''2C-I-NBOMe''') is a derivative of the [[Phenethylamines|substituted phenethylamine]] [[Psychedelics|psychedelic]] [[2C-I]], discovered in 2003 by Ralf Heim at the Free University of Berlin,<ref name="Ralf Heim PhD. (2010-02-28)">Ralf Heim PhD. (2010-02-28) "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2-Methoxybenzyl-Partialstruktur. Entwicklung eines neuen Struktur-Wirkungskonzepts." | http://www.diss.fu-berlin.de/diss/receive/FUDISS_thesis_000000001221 (in German). diss.fu-berlin.de. Retrieved 2013-05-10.</ref> and subsequently investigated by a team at Purdue University led by [[David E. Nichols|David Nichols]].<ref name="Michael Robert Braden PhD. (2007)">Michael Robert Braden PhD. (2007). "Towards a biophysical understanding of hallucinogen action." | http://proquest.umi.com/pqdlink?Ver=1&Exp=01-23-2014&FMT=7&DID=1417800971&RQT=309&attempt=1&cfc=1 Purdue University. Retrieved 2012-08-08.</ref> The chemical had no history of human use prior to being sold online as a [[designer drug]] in 2010.
Retrieved from "http://psy.st/wiki/25I-NBOMe"